We use own cookies and thirds to offer you better service More information Accept

The Invent Farma Group develops, patents and implements its own synthesis routes for the manufacture of active substances

api supplier

Inke facilities enable the manufacture of active substances in a batches ranging from 1 to 300 Kg. Inke has facilities and services to perform all types of organic synthesis reactions (hydrogenation, reduction, oxidation, etc.) within a temperature range from -25ºC to 200ºC and pressures from 0 to 20 bars. The final isolation operations (centrifuging, filtering, drying, screening, micronisation and supplying) are performed in controlled environment rooms and allow adjustment of the quality of the products manufactured to the customers' needs.

The products manufactured and the stability studies are performed in a modern Quality Control laboratory equipped with the latest technology in the industry.

The isolation, final treatment and analysis of active substances for use in respiratory therapies is performed at special containment facilities reducing the exposure of Inke workers to safe levels.

The Invent Farma Group develops, patents and implements its own synthesis routes for the manufacture of active substances. The Group has its own laboratories where professionals with a high level of training and experience develop and refine the processes for final transfer to Inke's manufacturing plants.

The Invent Farma Group has specialised in the development and manufacture of active substances for use in respiratory therapies. Given the specific requirements for these products, this strategic commitment has involved an increase in the level of technical and regulatory collaboration with our customers and the implementation of new containment facilities that have reduced the exposure of our workers to safe levels.